ImaginAb Plataforma de Tecnología Vendida a Telix
Funding | Jan 22, 2025 | PR Newswire Cision ImaginAb, Inc.
ImaginAb, Inc., una empresa biotecnológica global, ha firmado un acuerdo para vender su plataforma biológica patentada y línea de candidatos terapéuticos de próxima generación a Telix Pharmaceuticals Limited. El acuerdo también incluye una instalación de investigación centrada en el descubrimiento y la ingeniería de proteínas. La transacción permitirá a ImaginAb centrarse en el desarrollo de su candidato líder, CD8 ImmunoPET, en ensayos clínicos de fase 2, utilizado principalmente en oncología para medir la eficacia de inmunoterapias. Telix reconoce el valor de la plataforma, lo que representa un avance en agentes radiofarmacéuticos y ofrece la posibilidad de explorar nuevas áreas de enfermedades. Asesores financieros Jefferies LLC y Stifel, Nicolaus & Co. participaron en la transacción.
Sectors
- Biotechnology
- Pharmaceuticals
Geography
- United States – ImaginAb, the target company, is based in Inglewood, California, USA.
- Australia – Telix Pharmaceuticals Limited, the acquiring company, is based in Australia.
Industry
- Biotechnology – The article is primarily focused on a transaction involving biotechnology companies, specifically dealing with the development and acquisition of therapeutic and imaging platforms.
- Pharmaceuticals – The transaction and technologies discussed involve pharmaceuticals, specifically in developing therapeutic drugs and diagnostic imaging solutions in oncology.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| ImaginAb, Inc. | Target Company | Company | A biotechnology company focused on developing next-generation radiopharmaceuticals and imaging agents, currently in clinical phases. |
| Telix Pharmaceuticals Limited | Bidding Company | Company | A pharmaceutical company acquiring ImaginAb's innovative biological technology platform and therapeutic candidates. |
| Anna Wu | Founder of ImaginAb | People | Founder of ImaginAb, providing statements on the transaction and future focus of the company. |
| Jefferies LLC | Financial Advisor | Company | Acted as financial advisor for ImaginAb in the transaction. |
| Stifel, Nicolaus & Company, Incorporated | Financial Advisor | Company | Provided financial advisory services to ImaginAb in the deal. |